Table 2.
SNP | Population | GG | GA | AA | G | A | p Value* | OR | (95% CI) | |
---|---|---|---|---|---|---|---|---|---|---|
rs33996649 | Spain | SSc (n=599) | 0.960 | 0.040 | 0 | 0.979 | 0.0211 | |||
Controls (n=1128) | 0.932 | 0.068 | 0 | 0.966 | 0.0341 | 0.04¶ | 0.58 | 0.36 to 0.92 | ||
Belgium | SSc (n=187) | 0.952 | 0.048 | 0 | 0.976 | 0.0241 | ||||
Controls (n=236) | 0.949 | 0.051 | 0 | 0.975 | 0.0254 | 0.9 | 0.95 | 0.39 to 2.27 | ||
England | SSc (n=477) | 0.956 | 0.042 | 0.002 | 0.977 | 0.0231 | ||||
Controls (n=382) | 0.969 | 0.031 | 0 | 0.984 | 0.0157 | 0.28 | 1.48 | 0.73 to 3.01 | ||
Germany | SSc (n=354) | 0.966 | 0.034 | 0 | 0.983 | 0.0169 | ||||
Controls (n=285) | 0.958 | 0.042 | 0 | 0.979 | 0.0211 | 0.59 | 0.8 | 0.36 to 1.8 | ||
Italy | SSc (n=419) | 0.945 | 0.055 | 0 | 0.973 | 0.0274 | ||||
Controls (n=371) | 0.938 | 0.062 | 0 | 0.969 | 0.0310 | 0.68 | 0.88 | 0.49 to 1.59 | ||
Netherlands | SSc (n=185) | 0.959 | 0.041 | 0 | 0.979 | 0.0207 | ||||
Controls (n=263) | 0.951 | 0.049 | 0 | 0.975 | 0.0247 | 0.72 | 0.83 | 0.32 to 2.22 | ||
USA | SSc (n=1050) | 0.947 | 0.053 | 0 | 0.973 | 0.0267 | ||||
Controls (n=693) | 0.958 | 0.042 | 0 | 0.979 | 0.0209 | 0.28 | 1.28 | 0.81to 2.02 | ||
Sweden | SSc (n=191) | 0.974 | 0.026 | 0 | 0.987 | 0.0131 | ||||
Controls (n=280) | 0.946 | 0.054 | 0 | 0.973 | 0.0268 | 0.15 | 0.48 | 0.17 to1.34 | ||
Pooled† | SSc(n=3422) | 0.954 | 0.045 | 0 | 0.977 | 0.0230 | ||||
Controls (n=3638) | 0.947 | 0.053 | 0 | 0.973 | 0.0530 | |||||
Fixed model | 0.36 | 0.89 | 0.72 to 1.12 | |||||||
| ||||||||||
SNP | Population | CC | CT | TT | C | T | p Value* | OR | (95% CI) | |
| ||||||||||
rs2476601 | Spain | SSc (n=636) | 0.857 | 0.137 | 0.006 | 0.925 | 0.075 | |||
Controls (n=1128) | 0.857 | 0.136 | 0.007 | 0.925 | 0.075 | 0.98 | 0.99 | 0.77 to 1.29 | ||
Belgium | SSc (n=189) | 0.788 | 0.212 | 0.000 | 0.894 | 0.106 | ||||
Controls (n=256) | 0.859 | 0.129 | 0.012 | 0.927 | 0.073 | 0.08 | 1.51 | 0.95 to 2.42 | ||
England | SSc (n=463) | 0.793 | 0.201 | 0.006 | 0.893 | 0.107 | ||||
Controls (n=373) | 0.853 | 0.147 | 0.000 | 0.926 | 0.074 | 0.04¶ | 1.5 | 1.07 to 2.12 | ||
Germany | SSc (n=343) | 0.802 | 0.175 | 0.023 | 0.889 | 0.111 | ||||
Controls (n=288) | 0.774 | 0.212 | 0.014 | 0.880 | 0.120 | 0.62 | 0.92 | 0.65 to 1.3 | ||
Italy | SSc (n=383) | 0.890 | 0.104 | 0.005 | 0.943 | 0.057 | ||||
Controls (n=371) | 0.935 | 0.059 | 0.005 | 0.965 | 0.035 | 0.08¶ | 1.68 | 1.02 to 2.76 | ||
Netherlands | SSc (n=190) | 0.805 | 0.189 | 0.005 | 0.900 | 0.100 | ||||
Controls (n=277) | 0.819 | 0.177 | 0.004 | 0.908 | 0.092 | 0.68 | 1.1 | 0.7 to 1.71 | ||
Sweden | SSc (n=175) | 0.789 | 0.200 | 0.011 | 0.889 | 0.111 | ||||
Controls (n=279) | 0.789 | 0.190 | 0.022 | 0.884 | 0.116 | 0.82 | 0.95 | 0.62 to 1.45 | ||
Dieudé et al19‡ | SSc (n=1018) | 0.820 | 0.172 | 0.008 | 0.906 | 0.094 | ||||
Controls (n=1004) | 0.828 | 0.163 | 0.009 | 0.909 | 0.091 | 0.73 | 1.04 | 0.84 to 1.28 | ||
Gourh et al20‡ | SSc (n=666) | 0.787 | 0.203 | 0.011 | 0.888 | 0.112 | ||||
Controls (n=430) | 0.844 | 0.147 | 0.009 | 0.917 | 0.083 | 0.06¶ | 1.39 | 1.03 to 1.87 | ||
Pooled§ | SSc (n=4063) | 0.819 | 0.173 | 0.009 | 0.905 | 0.095 | ||||
Controls (n=4406) | 0.843 | 0.148 | 0.008 | 0.917 | 0.083 | |||||
Fixed model | 0.03¶ | 1.15 | 1.03 to 1.28 |
p Value for the minor allele.
I2=17.6%, Breslow–Day p=0.281 Q=8.49 p=0.29; The statistical power for this pooled analysis was 97%.
The authors of those papers provided by personal communication the actualisation and specific data of their works.
I2=33.8%, Breslow–Day p=0.145 Q=12.08 p=0.15. The statistical power for this pooled analysis was 100%.
False discovery rate correction p value.
SNP, single nucleotide polymorphism; SSc, systemic sclerosis.